Fonte: Drug Metabolism and Drug Interactions. Nome do evento: Santorine Conference Biologie Prospective. Unidade: FCF
Assuntos: POLIMORFISMO, DOENÇAS CARDIOVASCULARES
ABNT
LUCHESSI, André Ducati et al. Relationship of CYP2C9, CYP2C19 and ABCC3 polymorphisms and platelet response to aspirin and clopidogrel in acute coronary syndrome patients. Drug Metabolism and Drug Interactions. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 08 nov. 2024. , 2012APA
Luchessi, A. D., Germano, J. F., Hirata, M. H., Hirata, R. D. C., Silbiger, V. N., Brion, M., et al. (2012). Relationship of CYP2C9, CYP2C19 and ABCC3 polymorphisms and platelet response to aspirin and clopidogrel in acute coronary syndrome patients. Drug Metabolism and Drug Interactions. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Luchessi AD, Germano JF, Hirata MH, Hirata RDC, Silbiger VN, Brion M, Carracedo A, Tanajura LFL, Lima PHO, Hirata TDC, Sousa AG. Relationship of CYP2C9, CYP2C19 and ABCC3 polymorphisms and platelet response to aspirin and clopidogrel in acute coronary syndrome patients. Drug Metabolism and Drug Interactions. 2012 ; 27( 3): A28 res. B14.[citado 2024 nov. 08 ]Vancouver
Luchessi AD, Germano JF, Hirata MH, Hirata RDC, Silbiger VN, Brion M, Carracedo A, Tanajura LFL, Lima PHO, Hirata TDC, Sousa AG. Relationship of CYP2C9, CYP2C19 and ABCC3 polymorphisms and platelet response to aspirin and clopidogrel in acute coronary syndrome patients. Drug Metabolism and Drug Interactions. 2012 ; 27( 3): A28 res. B14.[citado 2024 nov. 08 ]